The rise of Viagra initially sparked a period of growth for the drug industry, but recent shifts present a complicated outlook for shareholders. Off-patent competitors are eroding profits, and ongoing patent challenges https://murraydlar829462.pages10.com/the-blue-pill-and-pharma-a-precarious-play-76593422